期刊文献+

吲哚胺2,3双加氧酶在诊断肝移植急性排斥中的作用 被引量:5

Role of indoleamine 2, 3-dioxygenase in diagnosing rat' s acute rejection after liver transplantation
原文传递
导出
摘要 目的探讨外周血吲哚胺2,3双加氧酶(IDO)基因表达对大鼠肝移植急性排斥反应(AR)的诊断价值。方法建立大鼠原位肝移植模型,分为4组:A组:同基因移植组(Wistar—Wistar,n=32);B组:异基因移植组(SD—Wistar,n=32);C组:异基因移植+长期环孢素A组(CsA,n=32);D组:异基因移植+短期CsA组(用药剂量同C组,第3天起停药,n=32)。应用实时聚合酶链反应(Real—timePCR)方法分别检测术后第0、1、2、3、4、5、7、9天外周mIDO mRNA值,同时检测各时间点血清谷草转氨酶(AST)、总胆红素(T—BIL)、碱性磷酸酶(ALP)水平,并取肝脏病理切片。结果A组外周血IDO mRNA呈持续低水平,AST、T—BIL、ALP逐渐降至正常,病理无排斥反应。C组检测结果与A组相似。B组IDO mRNA显著上升为术后第2天(P〈0.05),AST、T—BIL、ALP值显著上升为术后4d(P〈0.01),病理切片判断轻度排斥为术后5d(χ^2=4.8,P〈0.05)。D组IDOmRNA显著上升为术后第4天(P〈0.05),AST、T—BIL、ALP值显著上升为术后5d(P〈0.01),病理切片判断轻度排斥为术后7d(χ^2=4.8,P〈0.05)。结论外周血IDO mRNA检测可较病理检查更早诊断大鼠肝移植AR的发生,且方法简单、安全。 Objective To study the diagnostic value of indoleamine 2, 3-dioxygenase (IDO) gene expression in acute liver rejection in rat orthotopic liver transplantation model. Methods The rat orthotopic liver transplantation models were divided into four groups: group A, isograft transplantation group (Wistar to Wistar) ; group B, allograft transplantation (SD to Wistar) ; group C, allograft transplantation and cyclosporine; Group D, allograft transplantation and cyclosporine (the drug was withdrawn on the 3rd day after the operation). The samples (peripheral blood and liver tissue) were obtained on the operation day, 1st, 2rid, 3rd, 4th, 5th, 7th and 9th day post-operation. Luorescent quantitative polymerase chain reaction (PCR) , pathological study and serum test were performed on each sample. Results In groups A and C, the IDO mRNA was expressed at a low level, aspartate aminotransferase (AST), total bilirubin (T-BIL) and alkaline phosphatase (ALP) were decreased to the normal level, and the pathological test found no acute rejection (AR). In group B, the IDO mRNA was dramatically increased on the day 2 ( P 〈 0. 05 ), AST, T-BIL and ALP rose dramatically on the day 4 (P 〈 0. 05) , and mild AR was detected on the day 5 (χ^2 = 4. 8,P 〈 0. 05 ). In group D, the IDO mRNA was dramatically increased on the day 4 ( P 〈 0. 05 ) , AST, T-BIL and ALP rose dramatically on the day 5 ( P 〈 0. 01 ), and mild AR was detected on the day 7 (χ^2 = 4.8, P 〈 0. 05 ). Conclusion Comparing with pathological study, detecting IDO mRNA of peripheral blood can diagnose AR of rat at earlier stage and the technique is safe and simple.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第7期1123-1126,共4页 Chinese Journal of Experimental Surgery
关键词 吲哚胺2 3双加氧酶 肝移植 急性排斥反应 Indoleamine 2,3-dioxygenase Liver transplantatation Acute rejection
  • 相关文献

参考文献9

  • 1Katz JB,Muller AJ,Prendergast GB.Indoleanmine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.Immunological Reviews,2008,222:206-221.
  • 2Kamada N,Calne RY.A surgical experience with five hundred thirty liver transplantation in the rat.Surgery,1983,93:64-68.
  • 3An International Panel.Banff schema for grading liver allograft rejection:an international consensus document.Hepatology,1997,25:658-663.
  • 4秦涛,申明媚,毕德琼,张宏伟,潘延凤.人IκBα突变体在大鼠肝移植急性排斥反应中的作用[J].中华实验外科杂志,2006,23(12):1486-1487. 被引量:2
  • 5Bonney EA,Matzinger P.Much IDO about pregnancy.Nature Medicine,1998,4:1128-1129.
  • 6Oliveira V,Sawitzki B,Chapman S.Anti-CD4-mediated selection of Treg in vitro-in vitro suppression does not predict in vivo capacity to prevent graft rejection.Eur J Immunol,2008,38:1677-1688.
  • 7戴向晨,刘彤,瞿紫微,朱理玮,王鹏志.诱导小鼠树突细胞表达吲哚胺2,3双加氧酶的研究[J].中华实验外科杂志,2006,23(12):1539-1541. 被引量:5
  • 8Lin YC,Chen CL,Nakano T,et al.Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance.J Gastroenterol Hepatol,2008,23:243-250.
  • 9唐华美,徐军明,裘国强,夏强,李克,裘正军,彭志海.肝移植急性排斥反应的诊断与治疗[J].临床外科杂志,2003,11(4):245-247. 被引量:1

二级参考文献19

  • 1秦涛,郑启昌,王继亮,卢欣,张勇.人突变型IκBα真核表达质粒的构建和鉴定[J].医学研究生学报,2005,18(10):872-874. 被引量:5
  • 2彭勇,李敬东,彭祥玉,刘海忠,刘作金,龚建平.核因子-κB圈套对Kupper细胞活化的抑制作用及其机制[J].中华实验外科杂志,2006,23(7):815-817. 被引量:7
  • 3Fridell JA, Jain A, Reyes J, et al. Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus[J]. Transplantation, 2002, 74 : 1721-1724.
  • 4Portmann BC. Transplantation pathology[M]. In: Macsween RNM,Burt AD, Portmann BC, et al, eds. Pathology of the liver. Fourth ed.Edinburgh: Elsevier science limited, 2002, 891-897.
  • 5Neuberger J. Incidence, timing, and risk factors for acute and chronic rejection[J]. Liver Transplant Surg, 1999, 5:30-36.
  • 6Adler M, Deprez C, Richaert et al. Cholestatic syndrome due to preservation injury after liver transplantation[J]. Transplant Prec, 1988, 20 : 644-665.
  • 7Neil DA, Hubscher SG. Are parenchymal changes in early post - transplant biopsies related to preservation- reperfusion injury or rejection[J]. Transplantation, 2001, 71(11) : 1566-1572.
  • 8Celec P. Nuclear factor kappa B-molecular biomedicine: the next generation. Biomed Pharmacother, 2004,58 : 365-371.
  • 9Kamada N, Calne RY. A surgical experience with five hundred thirty liver transplants in the rat. Surgery, 1983,93 : 64-69.
  • 10Zhaoli S, Wada T, Maemura K, et al. Hepatic allograft-derived Kupffer ceils regulate T cell response in rats. Liver transplantation, 2003,9 : 489-497.

共引文献5

同被引文献41

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部